FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:ARID1A-RPS6KA1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: ARID1A-RPS6KA1
FusionPDB ID: 6390
FusionGDB2.0 ID: 6390
HgeneTgene
Gene symbol

ARID1A

RPS6KA1

Gene ID

8289

6195

Gene nameAT-rich interaction domain 1Aribosomal protein S6 kinase A1
SynonymsB120|BAF250|BAF250a|BM029|C1orf4|CSS2|ELD|MRD14|OSA1|P270|SMARCF1|hELD|hOSA1HU-1|MAPKAPK1|MAPKAPK1A|RSK|RSK1|p90Rsk
Cytomap

1p36.11

1p36.11

Type of geneprotein-codingprotein-coding
DescriptionAT-rich interactive domain-containing protein 1AARID domain-containing protein 1AAT rich interactive domain 1A (SWI-like)BRG1-associated factor 250aOSA1 nuclear proteinSWI-like proteinSWI/SNF complex protein p270SWI/SNF-related, matrix-associated, ribosomal protein S6 kinase alpha-190 kDa ribosomal protein S6 kinase 1MAP kinase-activated protein kinase 1aMAPK-activated protein kinase 1aMAPKAP kinase 1aMAPKAPK-1aRSK-1S6K-alpha 1dJ590P13.1 (ribosomal protein S6 kinase, 90kD, polypeptide 1)p9
Modification date2020032920200327
UniProtAcc

O14497

Main function of 5'-partner protein: FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Binds DNA non-specifically. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). {ECO:0000250|UniProtKB:A2BH40, ECO:0000303|PubMed:12672490, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000324856, ENST00000374152, 
ENST00000457599, ENST00000540690, 
ENST00000526792, ENST00000374162, 
ENST00000488985, ENST00000530003, 
ENST00000531382, ENST00000374166, 
ENST00000374168, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score29 X 19 X 15=82654 X 7 X 4=112
# samples 457
** MAII scorelog2(45/8265*10)=-4.19901791296264
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(7/112*10)=-0.678071905112638
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: ARID1A [Title/Abstract] AND RPS6KA1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: ARID1A [Title/Abstract] AND RPS6KA1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)ARID1A(27102198)-RPS6KA1(26897940), # samples:3
Anticipated loss of major functional domain due to fusion event.ARID1A-RPS6KA1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ARID1A-RPS6KA1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ARID1A-RPS6KA1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
ARID1A-RPS6KA1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
ARID1A-RPS6KA1 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF.
ARID1A-RPS6KA1 seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF.
ARID1A-RPS6KA1 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
ARID1A-RPS6KA1 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF.
ARID1A-RPS6KA1 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF.
ARID1A-RPS6KA1 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
ARID1A-RPS6KA1 seems lost the major protein functional domain in Tgene partner, which is a kinase due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneARID1A

GO:0006337

nucleosome disassembly

8895581

HgeneARID1A

GO:0006338

chromatin remodeling

11726552

HgeneARID1A

GO:0030520

intracellular estrogen receptor signaling pathway

12200431

HgeneARID1A

GO:0030521

androgen receptor signaling pathway

12200431

HgeneARID1A

GO:0042921

glucocorticoid receptor signaling pathway

12200431

HgeneARID1A

GO:0045893

positive regulation of transcription, DNA-templated

12200431

TgeneRPS6KA1

GO:0043154

negative regulation of cysteine-type endopeptidase activity involved in apoptotic process

18402937



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:27102198/chr1:26897940)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across ARID1A (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across RPS6KA1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000374152ARID1Achr127105774+ENST00000374168RPS6KA1chr126873403+8609573128357301815
ENST00000374152ARID1Achr127105774+ENST00000374166RPS6KA1chr126873403+8565573128357301815
ENST00000324856ARID1Achr127102198+ENST00000374168RPS6KA1chr126897940+6937549537161121913
ENST00000324856ARID1Achr127102198+ENST00000374166RPS6KA1chr126897940+6926549537161121913
ENST00000324856ARID1Achr127102198+ENST00000526792RPS6KA1chr126897940+6343549537161121913
ENST00000324856ARID1Achr127102198+ENST00000374162RPS6KA1chr126897940+6343549537161121913
ENST00000324856ARID1Achr127102198+ENST00000530003RPS6KA1chr126897940+6926549537161121913
ENST00000324856ARID1Achr127102198+ENST00000531382RPS6KA1chr126897940+6188549537161121913
ENST00000457599ARID1Achr127102198+ENST00000374168RPS6KA1chr126897940+59154473050901696
ENST00000457599ARID1Achr127102198+ENST00000374166RPS6KA1chr126897940+59044473050901696
ENST00000457599ARID1Achr127102198+ENST00000526792RPS6KA1chr126897940+53214473050901696
ENST00000457599ARID1Achr127102198+ENST00000374162RPS6KA1chr126897940+53214473050901696
ENST00000457599ARID1Achr127102198+ENST00000530003RPS6KA1chr126897940+59044473050901696
ENST00000457599ARID1Achr127102198+ENST00000531382RPS6KA1chr126897940+51664473050901696
ENST00000374152ARID1Achr127102198+ENST00000374168RPS6KA1chr126897940+5700425828348751530
ENST00000374152ARID1Achr127102198+ENST00000374166RPS6KA1chr126897940+5689425828348751530
ENST00000374152ARID1Achr127102198+ENST00000526792RPS6KA1chr126897940+5106425828348751530
ENST00000374152ARID1Achr127102198+ENST00000374162RPS6KA1chr126897940+5106425828348751530
ENST00000374152ARID1Achr127102198+ENST00000530003RPS6KA1chr126897940+5689425828348751530
ENST00000374152ARID1Achr127102198+ENST00000531382RPS6KA1chr126897940+4951425828348751530
ENST00000540690ARID1Achr127102198+ENST00000374168RPS6KA1chr126897940+19835414331158241
ENST00000540690ARID1Achr127102198+ENST00000374166RPS6KA1chr126897940+19725414331158241
ENST00000540690ARID1Achr127102198+ENST00000526792RPS6KA1chr126897940+13895414331158241
ENST00000540690ARID1Achr127102198+ENST00000374162RPS6KA1chr126897940+13895414331158241
ENST00000540690ARID1Achr127102198+ENST00000530003RPS6KA1chr126897940+19725414331158241
ENST00000540690ARID1Achr127102198+ENST00000531382RPS6KA1chr126897940+12345414331158241
ENST00000324856ARID1Achr127102198+ENST00000374168RPS6KA1chr126897939+6937549537161121913
ENST00000324856ARID1Achr127102198+ENST00000374166RPS6KA1chr126897939+6926549537161121913
ENST00000324856ARID1Achr127102198+ENST00000526792RPS6KA1chr126897939+6343549537161121913
ENST00000324856ARID1Achr127102198+ENST00000374162RPS6KA1chr126897939+6343549537161121913
ENST00000324856ARID1Achr127102198+ENST00000530003RPS6KA1chr126897939+6926549537161121913
ENST00000324856ARID1Achr127102198+ENST00000531382RPS6KA1chr126897939+6188549537161121913
ENST00000457599ARID1Achr127102198+ENST00000374168RPS6KA1chr126897939+59154473050901696
ENST00000457599ARID1Achr127102198+ENST00000374166RPS6KA1chr126897939+59044473050901696
ENST00000457599ARID1Achr127102198+ENST00000526792RPS6KA1chr126897939+53214473050901696
ENST00000457599ARID1Achr127102198+ENST00000374162RPS6KA1chr126897939+53214473050901696
ENST00000457599ARID1Achr127102198+ENST00000530003RPS6KA1chr126897939+59044473050901696
ENST00000457599ARID1Achr127102198+ENST00000531382RPS6KA1chr126897939+51664473050901696
ENST00000374152ARID1Achr127102198+ENST00000374168RPS6KA1chr126897939+5700425828348751530
ENST00000374152ARID1Achr127102198+ENST00000374166RPS6KA1chr126897939+5689425828348751530
ENST00000374152ARID1Achr127102198+ENST00000526792RPS6KA1chr126897939+5106425828348751530
ENST00000374152ARID1Achr127102198+ENST00000374162RPS6KA1chr126897939+5106425828348751530
ENST00000374152ARID1Achr127102198+ENST00000530003RPS6KA1chr126897939+5689425828348751530
ENST00000374152ARID1Achr127102198+ENST00000531382RPS6KA1chr126897939+4951425828348751530
ENST00000540690ARID1Achr127102198+ENST00000374168RPS6KA1chr126897939+19835414331158241
ENST00000540690ARID1Achr127102198+ENST00000374166RPS6KA1chr126897939+19725414331158241
ENST00000540690ARID1Achr127102198+ENST00000526792RPS6KA1chr126897939+13895414331158241
ENST00000540690ARID1Achr127102198+ENST00000374162RPS6KA1chr126897939+13895414331158241
ENST00000540690ARID1Achr127102198+ENST00000530003RPS6KA1chr126897939+19725414331158241
ENST00000540690ARID1Achr127102198+ENST00000531382RPS6KA1chr126897939+12345414331158241

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000374152ENST00000374168ARID1Achr127105774+RPS6KA1chr126873403+0.0066721640.99332786
ENST00000374152ENST00000374166ARID1Achr127105774+RPS6KA1chr126873403+0.0066994030.99330056
ENST00000324856ENST00000374168ARID1Achr127102198+RPS6KA1chr126897940+0.0078965260.99210346
ENST00000324856ENST00000374166ARID1Achr127102198+RPS6KA1chr126897940+0.0078792560.99212074
ENST00000324856ENST00000526792ARID1Achr127102198+RPS6KA1chr126897940+0.0078395560.9921604
ENST00000324856ENST00000374162ARID1Achr127102198+RPS6KA1chr126897940+0.0078395560.9921604
ENST00000324856ENST00000530003ARID1Achr127102198+RPS6KA1chr126897940+0.0078792560.99212074
ENST00000324856ENST00000531382ARID1Achr127102198+RPS6KA1chr126897940+0.0075738210.99242616
ENST00000457599ENST00000374168ARID1Achr127102198+RPS6KA1chr126897940+0.0069679510.993032
ENST00000457599ENST00000374166ARID1Achr127102198+RPS6KA1chr126897940+0.0069267610.9930733
ENST00000457599ENST00000526792ARID1Achr127102198+RPS6KA1chr126897940+0.0073667360.9926333
ENST00000457599ENST00000374162ARID1Achr127102198+RPS6KA1chr126897940+0.0073667360.9926333
ENST00000457599ENST00000530003ARID1Achr127102198+RPS6KA1chr126897940+0.0069267610.9930733
ENST00000457599ENST00000531382ARID1Achr127102198+RPS6KA1chr126897940+0.0072599630.9927401
ENST00000374152ENST00000374168ARID1Achr127102198+RPS6KA1chr126897940+0.0069802290.99301976
ENST00000374152ENST00000374166ARID1Achr127102198+RPS6KA1chr126897940+0.0069773840.9930226
ENST00000374152ENST00000526792ARID1Achr127102198+RPS6KA1chr126897940+0.0069508920.99304914
ENST00000374152ENST00000374162ARID1Achr127102198+RPS6KA1chr126897940+0.0069508920.99304914
ENST00000374152ENST00000530003ARID1Achr127102198+RPS6KA1chr126897940+0.0069773840.9930226
ENST00000374152ENST00000531382ARID1Achr127102198+RPS6KA1chr126897940+0.0067500480.99325
ENST00000540690ENST00000374168ARID1Achr127102198+RPS6KA1chr126897940+0.0121192160.9878807
ENST00000540690ENST00000374166ARID1Achr127102198+RPS6KA1chr126897940+0.0123370240.987663
ENST00000540690ENST00000526792ARID1Achr127102198+RPS6KA1chr126897940+0.0081407720.99185926
ENST00000540690ENST00000374162ARID1Achr127102198+RPS6KA1chr126897940+0.0081407720.99185926
ENST00000540690ENST00000530003ARID1Achr127102198+RPS6KA1chr126897940+0.0123370240.987663
ENST00000540690ENST00000531382ARID1Achr127102198+RPS6KA1chr126897940+0.0050695010.99493045
ENST00000324856ENST00000374168ARID1Achr127102198+RPS6KA1chr126897939+0.0078965260.99210346
ENST00000324856ENST00000374166ARID1Achr127102198+RPS6KA1chr126897939+0.0078792560.99212074
ENST00000324856ENST00000526792ARID1Achr127102198+RPS6KA1chr126897939+0.0078395560.9921604
ENST00000324856ENST00000374162ARID1Achr127102198+RPS6KA1chr126897939+0.0078395560.9921604
ENST00000324856ENST00000530003ARID1Achr127102198+RPS6KA1chr126897939+0.0078792560.99212074
ENST00000324856ENST00000531382ARID1Achr127102198+RPS6KA1chr126897939+0.0075738210.99242616
ENST00000457599ENST00000374168ARID1Achr127102198+RPS6KA1chr126897939+0.0069679510.993032
ENST00000457599ENST00000374166ARID1Achr127102198+RPS6KA1chr126897939+0.0069267610.9930733
ENST00000457599ENST00000526792ARID1Achr127102198+RPS6KA1chr126897939+0.0073667360.9926333
ENST00000457599ENST00000374162ARID1Achr127102198+RPS6KA1chr126897939+0.0073667360.9926333
ENST00000457599ENST00000530003ARID1Achr127102198+RPS6KA1chr126897939+0.0069267610.9930733
ENST00000457599ENST00000531382ARID1Achr127102198+RPS6KA1chr126897939+0.0072599630.9927401
ENST00000374152ENST00000374168ARID1Achr127102198+RPS6KA1chr126897939+0.0069802290.99301976
ENST00000374152ENST00000374166ARID1Achr127102198+RPS6KA1chr126897939+0.0069773840.9930226
ENST00000374152ENST00000526792ARID1Achr127102198+RPS6KA1chr126897939+0.0069508920.99304914
ENST00000374152ENST00000374162ARID1Achr127102198+RPS6KA1chr126897939+0.0069508920.99304914
ENST00000374152ENST00000530003ARID1Achr127102198+RPS6KA1chr126897939+0.0069773840.9930226
ENST00000374152ENST00000531382ARID1Achr127102198+RPS6KA1chr126897939+0.0067500480.99325
ENST00000540690ENST00000374168ARID1Achr127102198+RPS6KA1chr126897939+0.0121192160.9878807
ENST00000540690ENST00000374166ARID1Achr127102198+RPS6KA1chr126897939+0.0123370240.987663
ENST00000540690ENST00000526792ARID1Achr127102198+RPS6KA1chr126897939+0.0081407720.99185926
ENST00000540690ENST00000374162ARID1Achr127102198+RPS6KA1chr126897939+0.0081407720.99185926
ENST00000540690ENST00000530003ARID1Achr127102198+RPS6KA1chr126897939+0.0123370240.987663
ENST00000540690ENST00000531382ARID1Achr127102198+RPS6KA1chr126897939+0.0050695010.99493045

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for ARID1A-RPS6KA1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
ARID1Achr127102198RPS6KA1chr12689793942581325YDDNSIMTFNLSQVVHRDLKPSNILY
ARID1Achr127102198RPS6KA1chr12689793944731491YDDNSIMTFNLSQVVHRDLKPSNILY
ARID1Achr127102198RPS6KA1chr12689793954136YDDNSIMTFNLSQVVHRDLKPSNILY
ARID1Achr127102198RPS6KA1chr12689793954951708YDDNSIMTFNLSQVVHRDLKPSNILY
ARID1Achr127102198RPS6KA1chr12689794042581325YDDNSIMTFNLSQVVHRDLKPSNILY
ARID1Achr127102198RPS6KA1chr12689794044731491YDDNSIMTFNLSQVVHRDLKPSNILY
ARID1Achr127102198RPS6KA1chr12689794054136YDDNSIMTFNLSQVVHRDLKPSNILY
ARID1Achr127102198RPS6KA1chr12689794054951708YDDNSIMTFNLSQVVHRDLKPSNILY

Top

Potential FusionNeoAntigen Information of ARID1A-RPS6KA1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ARID1A-RPS6KA1_27102198_26897939.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-A02:13IMTFNLSQV0.99490.6146514
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-A02:27IMTFNLSQV0.9940.5551514
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-A02:11IMTFNLSQV0.99080.5105514
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-A02:38IMTFNLSQV0.9880.5837514
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-B15:16MTFNLSQVV0.93080.8386615
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-B13:02MTFNLSQVV0.84390.7144615
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-B52:01MTFNLSQVV0.73460.9658615
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-A02:38SIMTFNLSQV0.99790.7172414
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-A31:02TFNLSQVVHR0.95390.5648717
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-A74:09MTFNLSQVVHR0.9640.5872617
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-A74:11MTFNLSQVVHR0.9640.5872617
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-A74:03MTFNLSQVVHR0.9640.5872617
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-A31:02MTFNLSQVVHR0.94040.5726617
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-C15:06MTFNLSQVV0.9990.7977615
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-C12:04MTFNLSQVV0.98870.9794615
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-C06:03MTFNLSQVV0.98790.9833615
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-C12:12MTFNLSQVV0.97920.8737615
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-C02:06MTFNLSQVV0.89820.9313615
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-B51:07MTFNLSQVV0.76460.9641615
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-A31:01TFNLSQVVHR0.94560.5409717
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-A31:01MTFNLSQVVHR0.97320.5564617
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-C15:02MTFNLSQVV0.99930.7685615
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-C15:05MTFNLSQVV0.99910.8037615
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-A02:03IMTFNLSQV0.99810.6378514
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-A68:02MTFNLSQVV0.99770.5932615
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-A69:01MTFNLSQVV0.99530.5832615
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-C16:04MTFNLSQVV0.9930.9517615
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-C12:03MTFNLSQVV0.97520.9488615
ARID1A-RPS6KA1chr127102198chr1268979395495HLA-A74:01MTFNLSQVVHR0.9640.5872617

Top

Potential FusionNeoAntigen Information of ARID1A-RPS6KA1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ARID1A-RPS6KA1_27102198_26897939.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ARID1A-RPS6KA1chr127102198chr1268979395495DRB3-0201NSIMTFNLSQVVHRD318
ARID1A-RPS6KA1chr127102198chr1268979395495DRB3-0209NSIMTFNLSQVVHRD318
ARID1A-RPS6KA1chr127102198chr1268979395495DRB3-0211NSIMTFNLSQVVHRD318
ARID1A-RPS6KA1chr127102198chr1268979395495DRB3-0216NSIMTFNLSQVVHRD318
ARID1A-RPS6KA1chr127102198chr1268979395495DRB3-0221NSIMTFNLSQVVHRD318
ARID1A-RPS6KA1chr127102198chr1268979395495DRB3-0224NSIMTFNLSQVVHRD318
ARID1A-RPS6KA1chr127102198chr1268979395495DRB3-0301NSIMTFNLSQVVHRD318
ARID1A-RPS6KA1chr127102198chr1268979395495DRB3-0303NSIMTFNLSQVVHRD318
ARID1A-RPS6KA1chr127102198chr1268979395495DRB5-0112IMTFNLSQVVHRDLK520

Top

Fusion breakpoint peptide structures of ARID1A-RPS6KA1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
6030MTFNLSQVVHRDLKARID1ARPS6KA1chr127102198chr1268979395495

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of ARID1A-RPS6KA1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN6030MTFNLSQVVHRDLK-7.64441-7.75781
HLA-B14:023BVN6030MTFNLSQVVHRDLK-5.94416-6.97946
HLA-B52:013W396030MTFNLSQVVHRDLK-6.36431-6.47771
HLA-B52:013W396030MTFNLSQVVHRDLK-5.79427-6.82957
HLA-A24:025HGA6030MTFNLSQVVHRDLK-7.67647-8.71177
HLA-A24:025HGA6030MTFNLSQVVHRDLK-6.37962-6.49302
HLA-B44:053DX86030MTFNLSQVVHRDLK-7.31799-7.43139
HLA-B44:053DX86030MTFNLSQVVHRDLK-5.80727-6.84257

Top

Vaccine Design for the FusionNeoAntigens of ARID1A-RPS6KA1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
ARID1A-RPS6KA1chr127102198chr126897939414SIMTFNLSQVAGCATCATGACCTTCAACCTCAGTCAGGTT
ARID1A-RPS6KA1chr127102198chr126897939514IMTFNLSQVATCATGACCTTCAACCTCAGTCAGGTT
ARID1A-RPS6KA1chr127102198chr126897939615MTFNLSQVVATGACCTTCAACCTCAGTCAGGTTGTG
ARID1A-RPS6KA1chr127102198chr126897939617MTFNLSQVVHRATGACCTTCAACCTCAGTCAGGTTGTGCACAGG
ARID1A-RPS6KA1chr127102198chr126897939717TFNLSQVVHRACCTTCAACCTCAGTCAGGTTGTGCACAGG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
ARID1A-RPS6KA1chr127102198chr126897939318NSIMTFNLSQVVHRDAACAGCATCATGACCTTCAACCTCAGTCAGGTTGTGCACAGGGAC
ARID1A-RPS6KA1chr127102198chr126897939520IMTFNLSQVVHRDLKATCATGACCTTCAACCTCAGTCAGGTTGTGCACAGGGACCTGAAG

Top

Information of the samples that have these potential fusion neoantigens of ARID1A-RPS6KA1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADARID1A-RPS6KA1chr127102198ENST00000324856chr126897939ENST00000374162TCGA-HU-A4GH

Top

Potential target of CAR-T therapy development for ARID1A-RPS6KA1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to ARID1A-RPS6KA1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to ARID1A-RPS6KA1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneARID1AC0024623Malignant neoplasm of stomach3CTD_human
HgeneARID1AC0038356Stomach Neoplasms3CTD_human
HgeneARID1AC1708349Hereditary Diffuse Gastric Cancer3CTD_human
HgeneARID1AC2239176Liver carcinoma3CTD_human
HgeneARID1AC0033578Prostatic Neoplasms2CTD_human
HgeneARID1AC0376358Malignant neoplasm of prostate2CTD_human
HgeneARID1AC0001418Adenocarcinoma1CTD_human
HgeneARID1AC0005684Malignant neoplasm of urinary bladder1CTD_human
HgeneARID1AC0005695Bladder Neoplasm1CTD_human
HgeneARID1AC0006413Burkitt Lymphoma1CTD_human
HgeneARID1AC0007138Carcinoma, Transitional Cell1CTD_human
HgeneARID1AC0009402Colorectal Carcinoma1CTD_human
HgeneARID1AC0009404Colorectal Neoplasms1CTD_human
HgeneARID1AC0010606Adenoid Cystic Carcinoma1CTD_human
HgeneARID1AC0014170Endometrial Neoplasms1CTD_human
HgeneARID1AC0027708Nephroblastoma1CTD_human
HgeneARID1AC0027819Neuroblastoma1CTD_human
HgeneARID1AC0036920Sezary Syndrome1CTD_human
HgeneARID1AC0079772T-Cell Lymphoma1CTD_human
HgeneARID1AC0079773Lymphoma, T-Cell, Cutaneous1CTD_human
HgeneARID1AC0205641Adenocarcinoma, Basal Cell1CTD_human
HgeneARID1AC0205642Adenocarcinoma, Oxyphilic1CTD_human
HgeneARID1AC0205643Carcinoma, Cribriform1CTD_human
HgeneARID1AC0205644Carcinoma, Granular Cell1CTD_human
HgeneARID1AC0205645Adenocarcinoma, Tubular1CTD_human
HgeneARID1AC0206656Embryonal Rhabdomyosarcoma1CTD_human
HgeneARID1AC0206698Cholangiocarcinoma1CTD_human
HgeneARID1AC0265338Coffin-Siris syndrome1CTD_human;GENOMICS_ENGLAND
HgeneARID1AC0279628Adenocarcinoma Of Esophagus1CTD_human
HgeneARID1AC0343640African Burkitt's lymphoma1CTD_human
HgeneARID1AC0345905Intrahepatic Cholangiocarcinoma1CTD_human
HgeneARID1AC0376407Granulomatous Slack Skin1CTD_human
HgeneARID1AC0476089Endometrial Carcinoma1CTD_human
HgeneARID1AC0920269Microsatellite Instability1CTD_human
HgeneARID1AC1721098Replication Error Phenotype1CTD_human
HgeneARID1AC2930471Bilateral Wilms Tumor1CTD_human
HgeneARID1AC2931822Nasopharyngeal carcinoma1CTD_human
HgeneARID1AC3805278Extrahepatic Cholangiocarcinoma1CTD_human
HgeneARID1AC4721444Burkitt Leukemia1CTD_human